Opinion
MDL 2445 13-MD-2445
08-30-2023
IN RE SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE) ANTITRUST LITIGATION
ORDER
MITCHELL S. GOLDBERG, J.
AND NOW, this 30th day of August, 2023, upon consideration of Plaintiffs' Motions for Partial Summary Judgment as to the Relevant Antitrust Market (Doc. Nos. 701 and 703), Defendant's Response (Doc. No. 723), Plaintiffs' Reply (Doc. No. 745), and Plaintiffs' Notices of Supplemental Authority (Doc. Nos. 781 and 792), it is hereby ORDERED that the Motion is DENIED.